Kolesar JM - Search Results

1

Programming Cell-Derived Vesicles with Enhanced Immunomodulatory Properties.

Neupane KR, Ramon GS, Harvey B, Chun B, Aryal SP, Masud AA, McCorkle JR, Kolesar JM, Kekenes-Huskey PM, Richards CI. Neupane KR, et al. Among authors: kolesar jm. Adv Healthc Mater. 2023 Oct;12(27):e2301163. doi: 10.1002/adhm.202301163. Epub 2023 Jul 9. Adv Healthc Mater. 2023. PMID: 37377147 Free PMC article.

2

Dendritic Cell Membrane-Derived Nanovesicles for Targeted T Cell Activation.

Harvey BT, Fu X, Li L, Neupane KR, Anand N, Kolesar JM, Richards CI. Harvey BT, et al. Among authors: kolesar jm. ACS Omega. 2022 Dec 9;7(50):46222-46233. doi: 10.1021/acsomega.2c04420. eCollection 2022 Dec 20. ACS Omega. 2022. PMID: 36570199 Free PMC article.

3

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment.

Schweer D, Anand N, Anderson A, McCorkle JR, Neupane K, Nail AN, Harvey B, Hill KS, Ueland F, Richards C, Kolesar J. Schweer D, et al. Front Oncol. 2023 Jan 11;12:1042730. doi: 10.3389/fonc.2022.1042730. eCollection 2022. Front Oncol. 2023. PMID: 36713536 Free PMC article.

4

Organelle Specific Macrophage Engineered Vesicles Differentially Reprogram Macrophage Polarization.

Neupane KR, Aryal SP, Harvey BT, Ramon GS, Chun B, McCorkle JR, Kolesar JM, Kekenes-Huskey PM, Richards CI. Neupane KR, et al. Among authors: kolesar jm. Adv Healthc Mater. 2024 Dec;13(30):e2401906. doi: 10.1002/adhm.202401906. Epub 2024 Sep 6. Adv Healthc Mater. 2024. PMID: 39240019

5

Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky.

Chen Q, Huang B, Anderson AM, Durbin EB, Arnold SM, Kolesar JM. Chen Q, et al. Among authors: kolesar jm. Front Oncol. 2023 Aug 17;13:1193487. doi: 10.3389/fonc.2023.1193487. eCollection 2023. Front Oncol. 2023. PMID: 37664066 Free PMC article.

6

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells.

Hill KS, Schuler EE, Ellingson SR, Kolesar JM. Hill KS, et al. Among authors: kolesar jm. Sci Rep. 2023 Dec 16;13(1):22383. doi: 10.1038/s41598-023-49928-y. Sci Rep. 2023. PMID: 38104159 Free PMC article.

7

Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights.

Ene A, Di J, Neltner JH, Pittman T, Arnold SM, Kolesar JM, Villano JL, Bachert SE, Allison DB. Ene A, et al. Among authors: kolesar jm. Front Oncol. 2023 Jan 31;13:1094274. doi: 10.3389/fonc.2023.1094274. eCollection 2023. Front Oncol. 2023. PMID: 36816978 Free PMC article.

8

Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.

McDonald HG, Zaki OA, Wright MJ, Jayswal R, Weiss H, Nair RT, Ganesh H, Ellis S, Kolesar JM, Moss J, Barry-Hundeyin M, Pandalai PK, Kim J, Patel RA, Cavnar MJ. McDonald HG, et al. Among authors: kolesar jm. Ann Surg Oncol. 2024 Feb;31(2):1252-1263. doi: 10.1245/s10434-023-14519-8. Epub 2023 Nov 25. Ann Surg Oncol. 2024. PMID: 38006531 Free PMC article.

9

[No title available]

[No authors listed] [No authors listed] PMID: 38006533

10

[No title available]

[No authors listed] [No authors listed] PMID: 39251510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters